Pharmaceuticals, Biotechnology and Life Sciences
BD has announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin …
After a $67.5 million jury verdict against Johnson & Johnson…
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
Vertex Pharmaceuticals Incorporated today announced the results of a Phase 3 study of Orkambi (lumacaftor/ivacaftor) in children with cystic fibrosis…
Neovacs, a player in active immunotherapy for the treatment of autoimmune diseases, has enroled the first U.S. patient in its international Phase IIb clinical study of IFNalpha Kinoid in lupus.
Amryt has received orphan drug designation from U.S. Food and Drug Administration (FDA) for its drug compound…
The first data analysis of the NKR-2 Phase I trial, run by the Belgia’s biopharmaceutical company Celyad, shows encouraging results
FDA granted accelerated approval to Lartruvo (olaratumab) injection, in combination with doxorubicin, for the treatment of adult patients…
Horizon Pharma has announced that Ravicti (glycerol phenylbutyrate) Oral Liquid is now available in Canada through its affiliate….
Alkermes, a global biopharmaceutical company developing medicines for the treatment of central nervous system…